Market Performance - A-shares showed strong performance with major indices rising, particularly in the TMT sector, where over 4,400 stocks increased in value [1][4] - The Hang Seng Index also performed well, with an intraday increase of over 2%, reaching a nearly three-year high, while the Hang Seng Tech Index rose over 4% [2][10] Sector Analysis - The TMT sector led the gains, with software services, internet, and IT equipment sectors showing the highest increases. Other sectors like diversified finance, advertising packaging, and media entertainment also performed well, while transportation infrastructure, engineering machinery, and steel sectors lagged [5] Brokerage Performance - The brokerage sector experienced a strong rally, with notable stocks such as First Capital Securities hitting the daily limit, and others like Xinda Securities and Dongfang Caifu also seeing significant gains [6] Concept Stocks - The DeepSeek concept stocks saw a notable rise, with the index increasing over 4% and several related stocks hitting the daily limit or rising more than 10% [7] Individual Stock Highlights - *ST Jiyuan experienced a significant drop of over 19% after announcing the termination of its pre-restructuring and restructuring matters, raising concerns about its potential delisting due to negative net asset projections for 2024 [8] - In the Hong Kong market, Kuaishou-W led the gains with an intraday increase of over 13%, while CK Hutchison saw a rise of over 10% following a previous surge of over 20% [11][12] Company Announcements - Jitu Express announced plans to handle 246.5 billion packages in 2024, a 31% increase from 2023, and highlighted its leading market position in Southeast Asia with a market share of 28.6%, up from 25.4% [14][15]

Investment Rating - Industry rating: "Overweight" (maintained) [2] Core Views - The market performance of traditional Chinese medicine (TCM) sector shows a 0.8% increase last week, while the overall pharmaceutical sector continues its rebound [1][4] - The expansion of grassroots TCM services is expected to drive demand growth, with the number of TCM clinics increasing from over 3,000 in 2015 to 42,000 in 2024, achieving nearly full coverage in community health service centers and township hospitals [8] - The TCM sector is experiencing a dual scenario of price governance and consumer recovery, presenting both pressures and opportunities [9] Summary by Sections Market Performance - Last week, the TCM index closed at 6446.65 points, up 0.8%, while the pharmaceutical sector index rose to 7368.1 points, an increase of 2.71% [4][14] - The relative performance of TCM compared to the CSI 300 index shows a decline of 2% over the past month and 17% over the past year [3][4] Valuation - The TCM sector's PE (ttm) is 26.87X, up 0.22X week-on-week, with a one-year maximum of 30.13X and a minimum of 22.58X. The PB (lf) is 2.32X, also up 0.02X week-on-week, with a one-year maximum of 2.65X and a minimum of 1.99X [6] - The TCM sector has a valuation premium of 110.86% compared to the CSI 300 index [6] Upstream TCM Materials - The TCM materials price index decreased slightly to 255.65 points, down 0.2% week-on-week, influenced by the Spring Festival market closure [7] Investment Suggestions - The report suggests focusing on companies with strong R&D capabilities and unique products that can benefit from price governance and consumer recovery [9][10] - Key investment themes include price governance, consumer recovery, and state-owned enterprise reform, with recommendations to pay attention to companies with strong brand power and product advantages [11]